Molecule.one
HoldPlatforms
A company building AI tools for chemical synthesis and reaction planning.
Why it's here
Placed in Hold: 1 article(s) of evidence from 1 source(s), led by research-stage coverage, with 0 in the last 30 days. Confidence 24%. Low accumulated evidence, so it defaults conservatively pending more signal.
Evidence (1)
- 7OpenAI Blog·6/17/2026researchOpenAI and Molecule.one improve a medicinal chemistry reaction with a near-autonomous AI chemist
OpenAI and Molecule.one reported that a near-autonomous AI chemist using GPT-5.4 helped improve a difficult drug-making reaction in medicinal chemistry. The work highlights how AI-assisted experimentation can support research into more effective synthesis routes.